A Study of Baricitinib (LY3009104) in Participants With COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Galcanezumab for Vestibular Migraine
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19
- Status
- COMPLETED
- Phase
- PHASE1
Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
- Status
- COMPLETED
- Phase
- PHASE1
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
- Status
- TERMINATED
- Phase
- PHASE3
Abemaciclib and Letrozole to Treat Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
- Status
- COMPLETED
- Phase
- PHASE3
LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
LY3214996 +/- HCQ in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of NKTR-358 (LY3471851) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Taltz in Combination With Enstilar for Psoriasis
- Status
- RECRUITING
- Phase
- PHASE4
A Study of LY3461767 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3127804 in Participants With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
Study of Tirzepatide in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide in Overweight and Very Overweight Participants
- Status
- COMPLETED
- Phase
- PHASE1